Valsartan salts

Details for Australian Patent Application No. 2009201898 (hide)

Owner Novartis AG

Inventors Oswald, Hans Rudolf; Marti, Erwin; Buhlmayer, Peter; Marterer, Wolfgang

Agent Davies Collison Cave

Pub. Number AU-B-2009201898

Parent 2005200648

Filing date 13 May 2009

Wipo publication date 4 June 2009

Acceptance publication date 9 February 2012

International Classifications

C07D 257/04 (2006.01) Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms

A61K 31/41 (2006.01) - having five-membered rings with two or more ring hetero atoms, at least one of which is nitrogen, e.g. tetrazole

A61P 9/12 (2006.01) Drugs for disorders of the cardiovascular system

Event Publications

28 May 2009 Complete Application Filed

4 June 2009 Application Open to Public Inspection

  Published as AU-B-2009201898

9 February 2012 Application Accepted

  Published as AU-B-2009201898

7 June 2012 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009201899-A Gaming System and Method of Gaming

2009201897-Agents for corneal or intrastromal administration to treat or prevent disorders of the eye